COVID-19 Disease Severity and Associated Factors among Ethiopian Patients: A study of the Millennium COVID-19 Care Center

Study Design, Setting and Population

An institution-based cross-sectional study was conducted at Millennium COVID-19 Care Center (MCCC), a 1000 bed makeshift hospital in Addis Ababa, Ethiopia dedicated for isolating and treating COVID-19 cases. The center is remodeled from the previous Millennium hall/ Addis park which was a multipurpose recreational, meeting and exhibition center. It is the first and also the largest center in the country with majority of the cases in the country admitted to the Center especially during the first few months of the pandemic in the country before the other COVID-19 wings in permanent hospitals and regional Centers started function. Even after that, it remained to be a center with the largest admission. At the beginning, since there were few cases, the MCCC and also other Centers in the country were used as both a quarantine and treatment center in order to halt the transmission of the disease. Therefore, anyone who tested positive for SARS-Cov-2 gets admitted to COVID-19 Centers despite the age, disease severity, presence of symptoms and co-morbidity status.

The source population was all patients admitted to MCCC with a confirmed diagnosis of COVID-19 using RT-PCR from June to August 2020.

The study population was all selected COVID-19 patients who were on treatment and follow up at MCCC during the three month period and who fulfill the inclusion criteria.

Sample Size Determination and Sampling Technique

The sample size to identify risk factors of disease severity was determined using a double population proportion formula with the assumptions of; 95% confidence interval, power of 80%, the proportion of males who had severe disease as 0.80, proportion of females who had non-severe disease as 0.75 and considering a non-response rate of 10%. Therefore, the total sample size calculated becomes 689 COVID-19 patients. A simple random sampling method using table of random numbers was used to select the study participants.

Eligibility criteria

All selected COVID-19 patients who were admitted to MCCC during the three months follow-up period and who consented to participate were included in the study.

Operational Definitions

COVID-19 disease [15]:

• – Mild Disease: characterized by fever, malaise, cough, upper respiratory symptoms, and/or less common features of COVID-19 (headache, loss of taste or smell etc…)

• – Moderate Disease: Patients with lower respiratory symptom/s. They may have infiltrates on chest X-ray. These patients are able to maintain oxygenation on room air.

• – Severe COVID-19 disease: Includes patients who have developed complications. The following features can define severe illness.

  • Hypoxia: SPO2 ≤ 93% on atmospheric air or PaO2:FiO2 < 300mmHg (SF ratio < 315)

  • Tachypnea: in respiratory distress or RR>30 breaths/minutes

  • More than 50% involvement seen on chest imaging

Data Collection Procedures and Quality Assurance

An interviewer-administered questionnaire that consists of the variables of interest was developed from the patient registration and follow up form which was adopted from the WHO patient admission and management guideline and used at the center for patient follow up.

The data collection tool was pretested on 35 randomly selected patients and their medical charts which were not included in the final data collection and necessary amendment on the data collection tool was made.

Training on the basics of the questionnaire and data collection technique was given for ten data collectors (BSc nurses and General practitioners) and two supervisors (General practitioner and public health specialist).

Data consistency and completeness was checked before an attempt was made to enter the code and analyze the data.

Statistical Analysis

The extracted data were coded, entered into Epi-Info version 7.2.1.0, cleaned, stored, and exported to SPSS version 23.0 software for analysis. Categorical covariates were summarized using frequencies and percentages and numerical variables were summarized with a mean value. A Chi-square test/ Fischer’s exact test was run to compare the underlying characteristics of the patients based on disease severity. A statistically significant difference was detected for variables with a P-value of ≤ 0.05. The presence of multi-collinearity was checked for the independent variables fit on the final model and the VIF result ranges from 1.081 to 1.314 showing that there is no multi-collinearity issue in the final mode.

The association between disease severity and determinant variables were analyzed using Multinomial Logistic Regression. Univariate analysis was done at 25% level of significance to screen out independent variables used in the multivariable multinomial Logistic regression model. The adequacy of the final model was assessed using goodness of fit test and the final model fitted the data well (Pearson x ² ₍₁₁₈₎ =141.005, p-value = 0.073 and Deviance x²₍₁₁₈₎ =134.542, p-value = 0.142). For the multinomial Logistic regression, 95% confidence interval for AOR was calculated and variables with p-value ≤ 0.05 were considered as statistically associated with COVID-19 disease severity at admission.

Ethics approval

The study was conducted after obtaining ethical clearance from St. Paul’s Hospital Millennium Medical College Institutional Review Board. After assessing their level of consciousness, written informed consent was obtained from the participants / parents or legal guardians for minors. The study had no risk/negative consequence on those who participated in the study. Medical record numbers were used for data collection and personal identifiers were not used in the research report. Access to the collected information was limited to the principal investigator and confidentiality was maintained throughout the project.

Socio-demographic, co-morbid illness and disease related characteristics and comparison based on disease severity

From the 689 samples selected, information was collected from 686 patients making the response rate 99.5%. The median age of the participants was 40.0 (IQR, 30.0-57.3) years. The majority (63.1%) were males. Two hundred sixty-seven (38.9%) of the patients had a history of one or more co-morbid illnesses. The most common co-morbid illness in the study population was hypertension (21.1%), followed by diabetes mellitus (16.6%), cardiac disease (5.2%) and Asthma (4.7%), tuberculosis (1.7%). Other co-morbid illnesses like chronic kidney disease and neurologic disorder constituted less than 2% of the co-morbid illnesses reported. Twenty-five (3.6%) of the patients were Khat chewers and nine (1.3%) were smokers.

A statistically significant difference in disease severity was found among the different groups of patients by age group, sex, co-morbid illness, hypertension, and diabetes mellitus. A significant proportion of patients 40 to 59 years (29.4% Vs 29.9% Vs 40.6%, p-value=0.0001) and ≥ 60 years (16.6% Vs 16.6% Vs 66.9%, p-value=0.0001) had severe disease and the younger age group of < 40 years had mild disease (46.2% Vs 41.1% Vs 12.7%, p-value=0.0001). Based on sex, a significantly higher proportion of female patients had mild disease (41.1% Vs 31.2% Vs 27.7%, p-value=0.021). On the contrary, males had severe disease (31.2% Vs 33.3% Vs 35.6%, p-value=0.021). A significantly higher proportion of patients with one or more co-morbid illnesses had severe disease followed by moderate and then mild disease (20.6% Vs 30.3% Vs 49.1%, p-value=0.0001). Similarly, patients with hypertension (17.2% Vs 29.7% Vs 53.1%, p-value=0.0001) and diabetes (12.3% Vs 28.9% Vs 58.8%, p-value=0.0001) had severe disease followed by moderate and then mild disease. (Table 1)

Presenting symptom related characteristics and comparison based on disease severity

The most common presenting symptom was cough (56.4%) followed by shortness of breath (26.9%), fatigue (23.2%), fever (20.9%), headache (16.5%), chest pain (16.1%), sore throat (13.7%), arthralgia (11.2%), myalgia (10.1%), and runny nose (5.1%).

As shown in Table 2, the chi-square test result shows that a significantly higher proportion of patients with any of the above presenting symptoms had sever disease, followed by moderate and then mild disease. (Table 2)

Results of risk factors of COVID-19 disease severity (Mild Vs Moderate Vs Severe)

Based on the result of the Univariate analysis at 25% level of significance; Age group, sex, hypertension, diabetes mellitus, fever, and headache were found to be significantly associated with COVID-19 disease severity (Mild Vs Moderate Vs Severe).

On the multivariable multinomial logistic regression at 5% level of significance; age group, hypertension, diabetes mellitus, fever, and headache were found to be significantly associated with COVID-19 disease severity. Accordingly, after adjusting for other covariates, for patients in the age range of 40 to 59 years and ≥ 60 years, the odds of having severe disease as compared with mild disease were 4.428 and 18.070 times than patients < 40 years, respectively (AOR= 4.43, 95% CI= 2.49, 7.85, p-value=0.0001 for 40-59 years and AOR=18.07, 95% CI= 9.29, 35.14, p-value=0.0001 for ≥ 60 years). Similarly, the odds of having severe disease as compared with moderate disease among patients 40 to 59 years and ≥ 60 years were 4.87 and 18.906 times than patients < 40 years, respectively (AOR= 4.87, 95% CI= 2.85, 8.32, p-value=0.0001 for 40-59 years and AOR= 18.91, 95% CI= 9.84, 36.33, p-value=0.0001 for ≥ 60 years). But age group didn’t show a significant association with disease severity between moderate and mild cases.

A significant association of sex with disease severity was found only between severe cases as compared with mild. Being male was associated with a 1.84 odds of having severe disease as compared with mild disease than females (AOR=1.84, 95% CI=1.12, 3.03, p-value=0.016).

Regarding co-morbid illness, having hypertension and diabetes was significantly associated with disease severity between moderate Vs mild and moderate Vs severe disease, but not between severe Vs moderate disease. For patients with hypertension and diabetes, the odds of having moderate disease as compared with mild disease were 2.30 and 2.61 times compared to patients with no such illnesses, respectively (AOR= 2.30, 95% CI= 1.27, 4.18, p-value=0.006 for hypertension and AOR= 2.61, 95% CI= 1.31, 5.19, p-value=0.007 for diabetes mellitus). Similarly, the odds of having severe disease as compared with mild disease for hypertensive and diabetic patients were 1.97 and 3.93 times patients with no such illnesses, respectively (AOR= 1.97, 95% CI= 1.08, 3.59, p-value=0.028 for hypertension and AOR= 3.93, 95% CI= 1.96, 7.85, p-value=0.0001 for diabetes mellitus).

Concerning presenting symptom, having fever and headache was significantly associated with disease severity; moderate Vs mild, severe Vs mild, and severe Vs moderate. The odds of having moderate disease as compared with mild disease for patients with fever and headache were 6.12 and 2.69 times than patients with no such symptoms, respectively (AOR= 6.12, 95% CI= 2.94, 12.72, p-value=0.0001 for fever; AOR= 2.69, 95% CI= 1.39, 5.22, p-value=0.003 for headache). The odds of having severe disease as compared with mild disease for patients with fever and headache were 13.22 and 4.82 times than patients with no such symptoms, respectively (AOR= 13.22, 95% CI= 6.11, 28.60, p-value=0.0001 for fever; AOR= 4.82, 95% CI= 2.32, 9.97, p-value=0.0001 for headache). Similarly, the odds of having severe disease as compared with moderate disease for patients with fever and headache were 2.16 and 1.79 times compared to patients with no such symptoms, respectively (AOR= 2.16, 95% CI= 1.29, 3.63, p-value=0.004 for fever; AOR= 1.79, 95% CI= 1.03 3.11, p-value=0.039 for headache). (Table 3)